Montelukast ameliorated pemetrexed-induced cytotoxicity in hepatocytes by mitigating endoplasmic reticulum (ER) stress and nucleotide oligomerization domain-like receptor protein 3 (NLRP3) activation

References

• Cao M, Chen W. Epidemiology of lung cancer in China. Thorac Cancer. 2019;10(1):3–7.
   PubMed Web of Science ®Google Scholar
• Singh A, Wu H, Zhang P, et al. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype. Mol Cancer Ther. 2010;9(8):2365–2376.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66.
   PubMed Web of Science ®Google Scholar
• Lorlatinib is active in drug-resistant NSCLC. Cancer Discov. 2016;6(8):OF1. doi:10.1158/2159-8290.CD-NB2016-087.
   Google Scholar
• Oxnard GR. The cellular origins of drug resistance in cancer. Nat Med. 2016;22(3):232–234.
   PubMed Web of Science ®Google Scholar
• Francis S, Orton A, Stoddard G, et al. Sequencing of postoperative radiotherapy and chemotherapy for locally advanced or incompletely resected non-small-cell lung cancer. J Clin Oncol. 2018;36(4):333–341.
   PubMed Web of Science ®Google Scholar
• Brower V. Adding radiotherapy to chemotherapy in advanced NSCLC. Lancet Oncol. 2017;18(11):e645.
   PubMed Web of Science ®Google Scholar
• Heinzl S. [Folic acid antagonists pemetrexed]. Med Monatsschr Pharm. 2004;27(7):220–222.
   PubMedGoogle Scholar
• Bosch-Barrera J, Gaztanaga M, Ceballos J, et al. Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancer. Onkologie. 2009;32(10):580–584.
   PubMedGoogle Scholar
• Ohe Y, Ichinose Y, Nakagawa K, et al. Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer. Clin Cancer Res. 2008;14(13):4206–4212.
   PubMed Web of Science ®Google Scholar
• Dubey S, Schiller JH. Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab. Oncologist. 2005;10(4):282–291.
   PubMed Web of Science ®Google Scholar
• Hsu JY, Wakelee H. Pemetrexed disodium for the treatment of NSCLC: an update. Drugs Today (Barc). 2008;44(9):669–678.
   PubMed Web of Science ®Google Scholar
• Qian T, Huang XE. Study of pemetrexed-based chemotherapy for patients with locally advanced or metastatic cancers. Asian Pac J Cancer Prev. 2015;16(11):4791–4795.
   PubMedGoogle Scholar
• Yan J, Zhong N, Liu G, et al. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells. Cell Death Dis. 2014;5(7):e1316.
   PubMedGoogle Scholar
• Matsudate Y, Murao K, Kubo Y. Chemotherapy-induced inflammation of seborrheic keratoses due to pemetrexed treatment. J Dermatol. 2017;44(5):602–603.
   PubMed Web of Science ®Google Scholar
• Walker AM, Stevens JJ, Ndebele K, et al. Evaluation of arsenic trioxide potential for lung cancer treatment: assessment of apoptotic mechanisms and oxidative damage. J Cancer Sci Ther. 2016;8(1):1–9.
   PubMedGoogle Scholar
• Chen X, Zhang X, Pan J. Effect of montelukast on bronchopulmonary dysplasia (BPD) and related mechanisms. Med Sci Monit. 2019;25:1886–1893.
   PubMed Web of Science ®Google Scholar
• Eriksson Y, Bostrom M, Sandelius A, et al. The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain. Cell Death Dis. 2018;9(7):775.
   PubMedGoogle Scholar
• Hon KL, Leung TF, Leung AK. Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses? Drug Des Devel Ther. 2014;8:839–850.
   PubMed Web of Science ®Google Scholar
• El-Boghdady NA, Abdeltawab NF, Nooh MM. Resveratrol and montelukast alleviate paraquat-induced hepatic injury in mice: modulation of oxidative stress, inflammation, and apoptosis. Oxid Med Cell Longev. 2017;2017:9396425.
   PubMed Web of Science ®Google Scholar
• Hamamoto Y, Ano S, Allard B, et al. Montelukast reduces inhaled chlorine triggered airway hyperresponsiveness and airway inflammation in the mouse. Br J Pharmacol. 2017;174(19):3346–3358.
   PubMed Web of Science ®Google Scholar
• Takeda K, Shiraishi Y, Matsubara S, et al. Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation. Br J Pharmacol. 2010;160(6):1399–1407.
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu JF. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN. Bioengineered. 2020;11(1):972–983.
   PubMed Web of Science ®Google Scholar
• Lu YH, Ma J, Lin J, et al. Cell membrane breakage and triggering T cell infiltration are involved in human telomerase reverse transcriptase (hTERT) promoter-driven novel peptide KK-64 for liver cancer gene therapy. Bioengineered. 2021;12(1):12708–12721.
   PubMedGoogle Scholar
• Chen YQ, Huang M, Yan Y, et al. Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis. Bioengineered. 2021;12(1):8447–8456.
   PubMed Web of Science ®Google Scholar
• Kheradpezhouh E, Zhou FH, Barritt GJ, et al. Oxidative stress promotes redistribution of TRPM2 channels to the plasma membrane in hepatocytes. Biochem Biophys Res Commun. 2018;503(3):1891–1896.
   PubMed Web of Science ®Google Scholar
• Piao X, Liu Z, Li Y, et al. Investigation of the effect for bisphenol A on oxidative stress in human hepatocytes and its interaction with catalase. Spectrochim Acta A Mol Biomol Spectrosc. 2019;221:221 117149.
   PubMed Web of Science ®Google Scholar
• Jia Y, Wang F, Guo Q, et al. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells. Redox Biol. 2018;19:375–387.
   PubMed Web of Science ®Google Scholar
• Ma X, Luo Q, Zhu H, et al. Aldehyde dehydrogenase 2 activation ameliorates CCl4-induced chronic liver fibrosis in mice by up-regulating Nrf2/HO-1 antioxidant pathway. J Cell Mol Med. 2018;22(8):3965–3978.
   PubMed Web of Science ®Google Scholar
• Gu LL, Shen ZL, Li YL, et al. Oxymatrine causes hepatotoxicity by promoting the phosphorylation of JNK and induction of endoplasmic reticulum stress mediated by ROS in LO2 cells. Mol Cells. 2018;41(5):401–412.
   PubMed Web of Science ®Google Scholar
• Lebeau J, Saunders JM, Moraes VWR, et al. The PERK arm of the unfolded protein response regulates mitochondrial morphology during acute endoplasmic reticulum stress. Cell Rep. 2018;22(11):2827–2836.
   PubMed Web of Science ®Google Scholar
• Junjappa RP, Patil P, Bhattarai KR, et al. IRE1alpha implications in endoplasmic reticulum stress-mediated development and pathogenesis of autoimmune diseases. Front Immunol. 2018;9:1289.
   PubMed Web of Science ®Google Scholar
• van Vliet AR, Garg AD, Agostinis P. Coordination of stress, Ca2+, and immunogenic signaling pathways by PERK at the endoplasmic reticulum. Biol Chem. 2016;397(7):649–656.
   PubMed Web of Science ®Google Scholar
• Shi TL, Zhang L, Cheng QY, et al. Xanthatin induces apoptosis by activating endoplasmic reticulum stress in hepatoma cells. Eur J Pharmacol. 2019;843:843 1–11.
   PubMed Web of Science ®Google Scholar
• Han CY, Rho HS, Kim A, et al. FXR inhibits endoplasmic reticulum stress-induced NLRP3 inflammasome in hepatocytes and ameliorates liver injury. Cell Rep. 2018;24(11):2985–2999.
   PubMed Web of Science ®Google Scholar
• Lebeaupin C, Proics E, de Bieville CH, et al. ER stress induces NLRP3 inflammasome activation and hepatocyte death. Cell Death Dis. 2015;6(9):e1879.
   PubMedGoogle Scholar
• Ye L, Zeng Q, Dai H, et al. Endoplasmic reticulum stress is involved in ventilator-induced lung injury in mice via the IRE1alpha-TRAF2-NF-kappaB pathway. Int Immunopharmacol. 2020;78:106069.
   PubMed Web of Science ®Google Scholar